If one compares normal lung tissue and small-lung cell lung cancer, the EGFR membrane expression is more frequent in NSCLC cases—it has been observed in 40–80% cases of NSCLC, including 24–89% of LSCCs and 23–46% of ACs [37,38,39,40]. Here, EGFR is linked to non-small cell lung carcinoma.